About the journal
- Page Path
-
- HOME
- ABOUT
- About the journal
| Journal Title: | Clinical and Molecular Hepatology | |
| Journal Abbreviation: | Clin Mol Hepatol | |
| Acronym: | CMH | |
| Publication Date: | Vol. 18, no. 2 (2012) - | |
| Frequency: | Quarterly | |
| Publisher: | Korean Association for the Study of the Liver | |
| Language: | English | |
| pISSN: | 2287-2728 | |
| eISSN: | 2287-285X | |
| DOI Prefix: | 10.3350 | |
| Continued By: | The Korean Journal of Hepatology | |
| Broad Subject Term(s): | Gastroenterology | |
| MeSH (NLM): | Biliary Tract Diseases Liver Diseases | |
| SC (SCI): | Gastroenterology & Hepatology | |
| Open Access: | OA-nc (http://creativecommons.org/licenses/by-nc/4.0/) | |
| Electronic Links: | http://e-cmh.org | |
| Indexed/Tracked/ Covered By: | Science Citation Index Expanded (SCIE), Medline, PubMed, PubMed Central, CrossRef, SCOPUS, KoreaMed, KoMCI, Directory of Open Access Journals and Google Scholar | |
-
Clinical and
Molecular
HepatologyPrint ISSN: 2287-2728
Online ISSN: 2287-285X
-
-
Video abstract
-
- Modulation of lymphatic vessels in management of liver disease and complications
- Metabolic dysfunction-associated steatotic liver disease across women’s reproductive lifespan and issues
- Examining the therapeutic landscape of beta-blockers in portal hypertension
- Immunopathogenesis of liver fibrosis in steatotic liver disease
- Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
- Recent updates on pharmacologic therapy in non-alcoholic fatty liver disease
- The role of the hepatic autonomic nervous system
- HBeAg-positive grey-zone patients: Treatment beyond guideline recommendations?
- Systemic therapy in advanced hepatocellular carcinoma
- Epidemiology and updated management for autoimmune liver disease
- Microbiome and metabolomics in alcoholic liver disease
- Personalized medicine in nonalcoholic fatty liver disease
- Acute on chronic liver failure in cirrhosis
- Current status and outcome of liver transplantation in South Korea
- History and future of hepatitis B virus control in South Korea
- Hepatocellular carcinoma statistics in South Korea
Impact Factor14.0First decision
07 Days
Publication after acceptance
04 Days
*Last 12 months
- MOST VIEWED (Last 6 months)
- MOST CITED (2023-2025)
|
|||||||
